News

Stanford scientists 'totally surprised' by potential Parkinson's treatment discovery
New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...
Psychology Today21h
5 Reasons People Don’t Disclose Their Parkinson’s
People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...
Parkinson's: Cough medicine may help slow down cognitive decline
Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...
Texan explores young-onset Parkinson’s in Audible comedy series ‘Shaky’
For Oak Cliff native Katherine Craft, the new audio comedy series Shaky is personal. The writer-director’s nine-episode ...
How A Cheap, 3D-Printed Pen May Be Able To Help Diagnose Parkinson's Early
Parkinson's disease is best treated when detected early, but the cost of those tests makes that difficult. A new, 3D-printed ...
Devdiscourse10d
AI can detect Parkinson’s disease through speech, language and voice changes
Parkinson’s disease, the second most common neurodegenerative disorder globally, is often associated with vocal impairments, ...
Explore more
Kirk Gibson foundation's CEO prepares to climb Mount Kilimanjaro with 1 leg
Former Tigers outfielder Kirk "Gibby" Gibson created the Parkinson's foundation after he was diagnosed with the disease in ...
European Medical Journal1d
Parkinson’s Dementia Trial: Does Ambroxol Work Biologically and Clinically?
Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.